Leukeran 5mg Tablets

Ülke: Avustralya

Dil: İngilizce

Kaynak: Department of Health (Therapeutic Goods Administration)

Aktif bileşen:

chlorambucil, Quantity: 5 mg

Mevcut itibaren:

Aspen Pharmacare Australia Pty Ltd

Farmasötik formu:

Tablet, uncoated

Kompozisyon:

Excipient Ingredients: lactose monohydrate; maize starch; pregelatinised maize starch; sucrose; quinoline yellow; magnesium stearate

Uygulama yolu:

Oral

Paketteki üniteler:

25 tablets

Sınıf:

Medicine Registered

Reçete türü:

(S4) Prescription Only Medicine

Terapötik endikasyonlar:

Treatment of Hodgkin's disease, certain forms of non-Hodgkin's lymphoma, chronic lymphocytic leukaemia, Waldenstrom's macroglobulinaemia, advanced ovarian adenocarcinoma. Leukeran has a significant effect in a proportion of patients with breast cancer.

Ürün özeti:

Visual Identification: Yellow biconvex tablet marked "Wellcome H2A".; Container Type: Bottle

Yetkilendirme durumu:

Registered

Yetkilendirme tarihi:

1991-08-02